Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses

Objectives: In the present study, we aimed to determine the candidate genes that may function as biomarkers to further distinguish patients with isocitrate dehydrogenase (IDH)-wildtype glioblastoma (GBM), which are heterogeneous with respect to clinical outcomes. Materials and Methods: We selected 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu-Qing, Wu, Fan, Li, Jing-Jun, Li, Yang-Fang, Liu, Xing, Wang, Zheng, Chai, Rui-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929203/
https://www.ncbi.nlm.nih.gov/pubmed/31921684
http://dx.doi.org/10.3389/fonc.2019.01433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929203/
https://www.ncbi.nlm.nih.gov/pubmed/31921684
http://dx.doi.org/10.3389/fonc.2019.01433

Ejemplares similares